[1] FREDDIE B, JACQUES F, ISABELLE S, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424. [2] 何咏竞. 肿瘤标志物联合检测在卵巢疾病诊断中的临床价值探讨[J]. 国际检验医学杂志,2018,39(7):888-890. [3] LEE R C, FEINBAUM R L, AMBROS V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin -14[J]. Cell,1993, 75(5):843-854. [4] DI L G, GAROFALO M, CROCE C M. MicroRNAs in cancer[J]. Annu Rev Pathol,2014,9:287-314. [5] ZHANG Z, XING T C, CHEN Y H, et al. Exosomemediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposure[J]. Biomed Pharmacother, 2018, 106:1135-1143. [6] MARTA G, ALESSANDRA P, CAMILLO R, et al. Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators[J]. Am J Cancer Res, 2017,7(6):1350-1371. [7] YUAN H L, WANG T, ZHANG K H. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer[J]. Onco Targets Ther,2018,11:3891-3900. [8] MENG F,HENSON R,LANG L,et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines[J]. Gastroenterology,2006,130:2113-2129. [9] YANG X,HU Q,HU L X,et al. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1[J]. Discov Med, 2017,24(131):75-85. [10] ZHU K P,ZHANG C L,MA X L,et al. Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells[J/OL]. J Cell Physiol, 2018. doi:10. 1002/jcp.27435. [11] BROZOVIC A, DURAN G E, WANG Y C. The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells[J]. Mol Oncol, 2015, 9(8):1678-1693. [12] 曾勇,李娜,王福花,等. 卵巢浆液性囊腺癌化疗耐药和化疗敏感组织中的miRNAs差异表达谱检测及生物信息学分析[J]. 现代肿瘤医学,2017,25(12):1870-1875. [13] PENG Y J,HE X J,CHEN H H,et al. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway[J/OL]. Biosci Rep,2018. doi:10.1042/BSR20181051. [14] ZHOU P J,ZHANG R,WANG Y,et al. Cepharanthine hydrochloride reverses the MDR1(P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals[J]. Oncotarget, 2017,8(67):111144-111160. [15] SONG H G, WU T Q, XIE D, et al. WBP2 downregulation inhibits proliferation by blocking YAP transcription and the EGFR/PI3K/Akt signaling pathway in triple negative breast cancer[J]. Cell Physiol Biochem, 2018,48(5):1968-1982. [16] LI B,DING C M,LI Y X,et al. MicroRNA145 inhibits migration and induces apoptosis in human nonsmall cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway[J]. Oncol Rep, 2018, 40(5):2944-2954. [17] JIANG N,HJORTH-JENSEN K,HEKMAT O,et al. In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth[J]. Oncogene,2015,34(21):2764-2776. [18] RADU M, LYLE K, HOEFLICH K P, et al. p21-activated kinase 2 regulates endothelial development and function through the Bmk1/Erk5 pathway[J]. Mol Cell Biol,2015,35(23):3990-4005. [19] LI X,WEN W H,LIU K D,et al. Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines[J]. J Biol Chem,2011,286(25):22291-22299. [20] LU H Z, LIU S J, ZHANG G, et al. PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas[J]. Nature, 2017, 550(7674):133-136. |